OSTEOARTHROSIS: NEW POSSIBILITIES FOR DELAYED-ACTING SYMPTOM-MODIFYING THERAPY
Objective: to study the efficacy, tolerability, and safety of Artradol in patients with knee osteoarthrosis.Subjects and methods. The investigation enrolled 35 patients of both sexes, mean age 63,45 ± 6,9 years, with stages II and III gonarthrosisand walking pain intensity > 40 mm visual anal...
Saved in:
| Main Authors: | N. A. Shostak, N. G. Pravdyuk, A. A. Klimenko, A. A. Kondrashov, V. S. Shemenkova, V. A. Egorova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/18 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knee osteoarthrosis: Clinical presentation, diagnosis, treatment
by: Vladimir Vasilyevich Badokin
Published: (2013-10-01) -
Chondroitin sulfate: the mechanisms of action, its efficacy and safety in the therapy of osteoarthrosis
by: S G Anikin, et al.
Published: (2012-09-01) -
Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01) -
Pathogenetic treatment for knee osteoarthrosis
by: Marina Stanislavovna Svetlova
Published: (2012-09-01) -
The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)